EPO Patents = 1

Trademarks = 1

Forward Citations = 3

Loading Chart...

3 inventors (with patents filed for the assignee):

Sorah Yoon (6 out of 10 patents)

Nagy Habib (6 out of 18 patents)

John J Rossi (6 out of 102 patents)

6 patents: Sort by Forward Citations

1. 11845938 - Aptamer compositions and the use thereof (2023-12-19),

2. 11427826 - RNA aptamers against transferrin receptor (TfR) (2022-08-30),

3. 11236341 - RNA aptamers against transferrin receptor (TFR) (2022-02-01),

4. 11219635 - Bi-specific aptamer (2022-01-11),

5. 11180761 - PDGFR RNA aptamers (2021-11-23),

6. 10550394 - Anti-cancer RNA aptamers (2020-02-04),

Company Overview

Apterna Limited is a leading software development company specializing in custom web and mobile application development. With a strong team of experienced developers, designers, and project managers, we deliver innovative solutions tailored to our clients' specific needs. Our expertise spans across various industries, including healthcare, finance, and e-commerce.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#479 in London

#2,679 in United Kingdom

London, United Kingdom

Apterna Limited

Forward Citations = 3

3 inventors:

Sorah Yoon (6 out of 10 patents)

Nagy Habib (6 out of 18 patents)

John J Rossi (6 out of 102 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apterna Limited. Retrieved from https://idiyas.com/company/apterna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]